The Food and Drug Administration on Thursday issued marketing granted orders for vaping products from Glas Inc., an independent vaping technology company based in Inglewood, California.
The authorized products include the company’s Glas G2 Device and its Blonde Tobacco pod, which contains 50 milligrams/milliliters of nicotine, according to the FDA's website.
While these products are authorized to be sold in the United States, it does not mean these products are safe, nor are they “FDA approved,” the agency said.
The FDA said it determined that the issuance of these marketing granted orders confirms that Glas Inc. has met the requirements of the Federal Food, Drug and Cosmetic (FD&C) Act and authorizes marketing of the new tobacco products. On Monday, Glas Inc., highlighted the milestone on its LinkedIn page, calling the FDA’s authorization its “first public recognition of our work through the Agency’s Premarket Tobacco Product Application (PMTA) process.”
“We look forward to continued engagement with regulators as we pursue authorization for the full Glas G2 portfolio, including menthol and flavored pods, which we anticipate in the near term,” the company said on LinkedIn.
The FDA last week released a new draft guidance on how it plans to evaluate PMTAs for flavored electronic nicotine delivery systems. The agency said it is open to evidence showing that some flavored products could help adult smokers switch from traditional cigarettes by giving them more flavor options. To date, the FDA said there are 41 e-cigarettes authorized by the agency. These are the only e-cigarettes that may be lawfully sold in the United States.
Members help make our journalism possible. Become a CSP member today and unlock exclusive benefits, including unlimited access to all of our content. Sign up here.